Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy of gemcitabine for locally advanced pancreatic cancer (JCOG1106)

被引：1

作者：

Fukutomi, Akira

Mizusawa, Junki

Katayama, Hiroshi

Nakamura, Satoaki

Ito, Yoshinori

Hiraoka, Nobuyoshi

Ioka, Tatsuya

Ueno, Makoto

Ikeda, Masafumi

Sugimori, Kazuya

Shimizu, Kyoko

Okusaka, Takuji

Ozaka, Masato

Yanagimoto, Hiroaki

Nakamori, Shoji

Azuma, Takeshi

Hosokawa, Ayumu

Sata, Naohiro

Mine, Tetsuya

Furuse, Junji

机构：

[1] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan

[2] Natl Canc Ctr, Clin Oncol Grp, Ctr Data, Ctr Res Adm & Support, Tokyo 104, Japan

[3] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan

[4] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan

[5] Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo, Japan

[6] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan

[7] Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan

[8] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan

[9] Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Yokohama, Kanagawa 232, Japan

[10] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo, Japan

[11] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan

[12] Japanese Fdn Canc Res, Canc Inst Hosp, Hepatobiliary & Pancreat Div, Tokyo, Japan

[13] Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Osaka, Japan

[14] Osaka Natl Hosp, Dept Hepatobiliary & Pancreat Surg, Osaka, Japan

[15] Kobe Univ, Dept Internal Med, Sch Med, Div Gastroenterol, Kobe, Hyogo 657, Japan

[16] Toyama Univ, Dept Gastroenterol & Hematol, Fac Med, Toyama 930, Japan

[17] Jichi Med Univ, Sch Med, Dept Surg, Shimotsuke, Japan

[18] Tokai Univ, Sch Med, Dept Gastroenterol & Hepatol, Isehara, Kanagawa 25911, Japan

[19] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期

关键词：

D O I：

10.1200/jco.2015.33.15_suppl.4116

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4116

引用

页数：1

共 50 条

[21] Phase I/ II Study of Concurrent Chemoradiotherapy With Gemcitabine and S-1 for Unresectable Locally Advanced Pancreatic Adenocarcinoma
Ioka, T.
Arimoto, N.
Ashida, R.
Takakura, R.
Nakamura, S.
Nishiyama, K.
Tanaka, S.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S451 - S451
[22] Oral S-1 With Concurrent Radiotherapy for Locally Advanced Pancreatic Cancer
Shinchi, H.
Takao, S.
Maemura, K.
Mataki, Y.
Kurahara, H.
Natsugoe, S.
PANCREAS, 2012, 41 (07) : 1160 - 1160
[23] Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: A Phase I-II study
Brade, Anthony
Brierley, James
Oza, Amit
Gallinger, Steven
Cummings, Bernard
MacLean, Martha
Pond, Gregory R.
Hedley, David
Wong, Shun
Townsley, Carol
Brezden-Masley, Christine
Moore, Malcolm
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (04): : 1027 - 1036
[24] Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG 0506
Ishii, H.
Furuse, J.
Boku, N.
Okusaka, T.
Ikeda, M.
Ohkawa, S.
Fukutomi, A.
Hamamoto, Y.
Nakamura, K.
Fukuda, H.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[25] A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis
Terashima, Kazuki
Demizu, Yusuke
Hashimoto, Naoki
Jin, Dongcun
Mima, Masayuki
Fujii, Osamu
Niwa, Yasue
Takatori, Kento
Kitajima, Naoto
Sirakawa, Sachiyo
Yonson, Ku
Hishikawa, Yoshio
Abe, Mitsuyuki
Sasaki, Ryohei
Sugimura, Kazuro
Murakami, Masao
RADIOTHERAPY AND ONCOLOGY, 2012, 103 (01) : 25 - 31
[26] Gemcitabine and S-1 Induction Chemotherapy Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancers
Maemura, Kosei
Mataki, Yuko
Kurahara, Hiroshi
Kawasaki, Yota
Iino, Satoshi
Sakoda, Masahiko
Uchikado, Yasuto
Arigami, Takaaki
Uenosono, Yoshikazu
Mori, Shinichiro
Ueno, Shinichi
Shinchi, Hiroyuki
Natsugoe, Shoji
ANTICANCER RESEARCH, 2017, 37 (01) : 233 - 237
[27] Phase I study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer
Sudo, Kentaro
Yamaguchi, Taketo
Ishihara, Takeshi
Nakamura, Kazuyoshi
Shirai, Yoshihiko
Nakagawa, Akihiko
Kawakami, Hiroyuki
Uno, Takashi
Ito, Hisao
Saisho, Hiromitsu
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 219 - 224
[28] Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506
Ishii, Hiroshi
Furuse, Junji
Boku, Narikazu
Okusaka, Takuji
Ikeda, Masafumi
Ohkawa, Shinichi
Fukutomi, Akira
Hamamoto, Yasuo
Nakamura, Kenichi
Fukude, Haruhiko
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (06) : 573 - 579
[29] Concurrent chemoradiotherapy with gemcitabine and S-1 for unresectable locally advanced pancreatic adenocarcinoma: A phase I study
Ioka, T.
Fukutake, N.
Ikezawa, K.
Tanaka, S.
Nakamura, S.
Nishiyama, K.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
[30] Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer
Okusaka, T
Ito, Y
Ueno, H
Ikeda, M
Takezako, Y
Morizane, C
Kagami, Y
Ikeda, H
BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 673 - 677

← 1 2 3 4 5 →